Search

everythinglearnresearchcommunity

for

Search:↓

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Fractional laser therapy may help regrow hair in alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Baricitinib may effectively treat oral lichen planus.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Nitroglycerin ointment is now used to treat several skin conditions with fewer side effects.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.